Used in pharmaceutical research as a key intermediate in the synthesis of histamine H3 receptor antagonists, which are investigated for treating neurological disorders such as Alzheimer's disease, schizophrenia, and attention deficit hyperactivity disorder (ADHD). Its structure mimics histamine, allowing it to interact with histaminergic pathways in the brain. Also employed in the development of kinase inhibitors for cancer therapy due to its ability to bind ATP sites in enzymes. Additionally, serves as a ligand in coordination chemistry for creating metal-organic frameworks with potential catalytic activity.